Market Newsdesk

ROCHESTER, N.Y., Dec. 21, 2020 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, has announced that the Vuzix Blade® Smart Glasses was used to aid the first AR total knee replacement surgery conducted in the United States. The operation was completed by an orthopedic surgeon in New York City at the Hospital for Special Surgery (HSS), which has been nationally ranked number one in orthopedics for 11 consecutive years.

The augmented reality knee replacement platform from Medacta, known as NextAR™ TKA, received clearance from the U.S. Food and Drug Administration (FDA) in July. It utilizes a preoperative CT scan of the patient’s knee for surgical planning and the use of augmented reality glasses during surgery. The Vuzix Blade Smart Glasses allow the orthopedic surgeon to visualize the structures of the knee and track progress in real time directly on the operative field, without having to look over at a computer screen.

“Vuzix Smart Glasses continue to be leveraged across healthcare to aid in the delivery of the next generation of clinical care such as surgeries that leverage augmented reality smart glasses, artificial intelligence and machine learning,” stated Paul Travers, Vuzix President and Chief Executive Officer.  “It’s a significant milestone for the augmented reality smart glasses industry and Vuzix is thrilled to be part of another industry first in healthcare.”

About Vuzix Corporation

Vuzix is a leading supplier of Smart-Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company’s products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 179 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2020 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, and Tokyo, Japan.  For more information, visit Vuzix website,  Twitter and Facebook pages.

Forward-Looking Statements Disclaimer

Certain statements contained in this news release are “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to opportunities in the medical industry and use cases for Vuzix Smart Glasses, the success of partner solutions and ability to secure and maintain government approvals, existing and future business opportunities with HSS and Medacta, and among other things the Company’s leadership in the Smart Glasses and AR display industry. They are generally identified by words such as “believes,” “may,” “expects,” “anticipates,” “should” and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

Media and Investor Relations Contact:

Ed McGregor, Director of Investor Relations, Vuzix Corporation [email protected] Tel: (585) 359-5985

Vuzix Corporation, 25 Hendrix Road, Suite A, West Henrietta, NY 14586 USA,
Investor Information – [email protected]www.vuzix.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/vuzix-blade-aids-first-augmented-reality-smart-glasses-based-total-knee-replacement-surgery-in-the-us-301196822.html

SOURCE Vuzix Corporation

STOCKHOLM, Dec. 21, 2020 /PRNewswire/ — G5 Entertainment announces the release of its new free-to-play match-3 puzzle game, Mayor Match, currently only available in the Apple App Store.

In Mayor Match players create and develop a new fully-fledged city by building, constructing, and transforming an empty parcel of land. In this game, players create their dream city by building houses, industrial buildings, urban farms, shopping malls and transit systems, whilst providing quality living conditions for the residents. As players build through the thousands of match-3 levels, they can enjoy the combination of city-building and immersive match-3 gameplay.

As with all new G5 games, Mayor Match has G5 Friends network built-in, making it possible to play with friends.

For additional information, please contact:
Vlad Suglobov, CEO, [email protected]
Stefan Wikstrand, CFO, +46 76 00 11 115

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/g5-entertainment-ab/r/g5-entertainment-releases-new-match-3-game-mayor-match,c3257157

View original content:http://www.prnewswire.com/news-releases/g5-entertainment-releases-new-match-3-game-mayor-match-301196821.html

SOURCE G5 Entertainment AB

NEW YORK, Dec. 21, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for PFE, NKE, KO, C, and FLWS.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report – Measures a stock’s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street’s opinion including a 12-month price forecast.

• PFE: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PFE&prnumber=122120203
• NKE: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NKE&prnumber=122120203
• KO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=KO&prnumber=122120203
• C: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=C&prnumber=122120203
• FLWS: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=FLWS&prnumber=122120203

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-pfizer-nike-coca-cola-citigroup-or-1-800-flowerscom-301196788.html

SOURCE InvestorsObserver

NEW YORK, Dec. 21, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for AGIO, CLVS, AQMS, COCP, and LAZR.

To see how InvestorsObserver’s proprietary scoring system rates these stocks, view the InvestorsObserver’s PriceWatch Alert by selecting the corresponding link.

• AGIO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=AGIO&prnumber=122120202
• CLVS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CLVS&prnumber=122120202
• AQMS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=AQMS&prnumber=122120202
• COCP: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=COCP&prnumber=122120202
• LAZR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=LAZR&prnumber=122120202

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver’s PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock’s overall suitability for investment.

View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-agios-pharmaceuticals-clovis-oncology-aqua-metals-cocrystal-pharma-or-luminar-technologies-301196785.html

SOURCE InvestorsObserver

NEW YORK, Dec. 21, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for TSLA, BNTX, ZM, BAC, and FUBO.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report – Measures a stock’s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street’s opinion including a 12-month price forecast.

• TSLA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=TSLA&prnumber=122120204
• BNTX: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=BNTX&prnumber=122120204
• ZM: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=ZM&prnumber=122120204
• BAC: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=BAC&prnumber=122120204
• FUBO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=FUBO&prnumber=122120204

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-tesla-biontech-zoom-video-bank-of-america-or-fubotv-301196782.html

SOURCE InvestorsObserver

LAS VEGAS, Dec. 21, 2020 /PRNewswire/ — UMAX Group Corp. (Pink Sheets (Alternative Reporting Pink: UMAX) – UMAX releases a review of important events in the past year as well as an overview of business plans for calendar year 2021.

Mr. Fletcher (President and CEO of the Company), states…”The calendar year 2020 has brought positive changes to the company and laid the foundation for the upcoming year. Since taking control of UMAX during the first quarter of this year I have been focused on taking the necessary actions to get UMAX current with OTC Markets and also taking the necessary actions to make changes in the capital structure necessary to make UMAX attractive to both market investors and potential acquisition targets.  These corporate actions culminated with our first acquisition in the fourth quarter of this year with the acquired of Home Foam Corporation in November of 2020. 

The changes to its capital structure included reducing the authorized common stock from 1,850,000,000 shares to 500,000 shares amended in the articles of Incorporation and the cancellation of 500,000,000 shares owned by the controlling shareholder.  This reduced the issued shares by 89% and should be concluded by the end of January. Once these shares of Common Stock are cancelled, UMAX will trade at a more normalized market capitalization (with only 60,472,27 shares of Common Stock outstanding). Both of these corporate actions are pivotal to our acquisition plans for calendar year 2021.”

As previously announced and stated above, UMAX acquired 100% of the equity of Home Foam Corporation (“Home Foam”), a commercial operation which specializes in architectural foam (EPS) design products. These products include columns, caps, bases, medallions, railings, balconies, balustrades, shutters, window trims and sills, crown moldings and interior & exterior moldings. Home Foam also provides ornamental foam pop-outs such as window treatments for outside of new homes for several of the largest stucco subcontractors and plaster companies in Las Vegas, Nevada. Additionally, Home Foam cuts foam for packaging inserts for shipping companies as well as geo-foam for highway and road development.  The company also manufactures shutters for some of the largest regional home building companies for newly constructed residential homes.  Home Foam has a basic web site at www.HomeFoamUSA.com which is currently being upgraded to be a full company and consumer facing, ecommerce-based web site.

Home Foam works expanded polystyrene (EPS) or extruded polystyrene (XPS), which is valued for its insulating and cushioning properties. Foam polystyrene can be more than 95 percent air and is widely used to make home and appliance insulation, lightweight protective packaging, surfboards, foodservice and food packaging, automobile parts, roadway, and road bank stabilization systems and more. Currently Home Foam fabricates shapes from polystyrene per specifications of its clients which includes event designs and packaging, as well as foam walls, columns, and crown molding for home builders. Utilizing heat cutting technology we can cut almost any shape and form.

Mr. Fletcher (President and CEO of UMAX) further stated…”The acquisition of Home Foam Corporation was an initial step for UMAX to acquire additional vertical and horizontal basis cash flow positive operations in the home building industry.  With the current client base of Home Foam, it is anticipated that we will generate approximately $2.0M to $6m USD in revenue in calendar year 2021.  What the most exciting reason we acquired this particular subsidiary is Home Foam is in the final process of completing the closing of several new clients during the first quarter of 2021 that would potentially increase revenue by a multiple of 5 to 7 times our projected current revenue. We anticipate making an announcement with regards to these new clients by the 2^nd Quarter of 2021.”

Home Foam currently operates a 12,500 square foot warehouse located in Las Vegas, Nevada. The current warehouse provides services for over 50 customers and currently has 13 full-time employees. During the first quarter of 2021, it will be moving to a new location which has 23,500 square feet of operational space due to the increased client base and increased work orders we are expecting in calendar year 2021.  This location is brand new and currently being built out to Home Foam’s specifications.

About Us

UMAX Group Corp. is a Nevada corporation, is a public quoted Pink Sheet issuer under the ticker symbol “UMAX”. Currently, UMAX has one operational subsidiary, Home Foam Corporation (Nevada Corporation), which specializes in architectural foam (EPS) design products. This includes columns, caps, bases, medallions, railings, balconies, balustrades, shutters, window trims and sills, crown moldings and interior & exterior moldings. Additionally, they provide ornamental foam pop-outs such as window treatments for outside of new homes for stucco subcontractors and plaster companies.  Additionally, Home Foam cuts foam for packaging inserts for shipping companies as well as geo-foam for highway and road development.  The company also manufactures shutters for some of the largest regional home building companies for newly constructed residential homes.  The company currently operates a 12,500 square foot warehouse located in Las Vegas, Nevada. The warehouse provides services for over 50 customer and currently has 13 full-time employees. Home Foam has plans to participate in the home building market in the Southwest Unites States during calendar year 2021. The company will eventually develop its own patented building system using EPS Foam products and a patented stucco-based coating.  The coating insures higher R-values factors than traditional wood-built residences thus lower energy monthly cost.  The company is also continually searching for companies that would expand the footprint in the home building industry for partnerships of acquisition.

Forward Looking Statement

Certain statements that we make may constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning future strategic objectives, business prospects, anticipated savings, financial results (including expenses, earnings, liquidity, cash flow and capital expenditures), industry or market conditions, demand for and pricing of our products, acquisitions and divestitures, anticipated results of litigation and regulatory developments or general economic conditions. In addition, words such as believes, expects, anticipates, intends, plans, estimates, projects, forecasts, and future or conditional verbs such as will, may, could, should, and would, as well as any other statement that necessarily depends on future events, are intended to identify forward-looking statements. Forward-looking statements are not guarantees, and they involve risks, uncertainties and assumptions. Although we make such statements based on assumptions that we believe to be reasonable, there can be no assurance that actual results will not differ materially from those expressed in the forward-looking statements. We caution investors not to rely unduly on any forward-looking statements and urge you to carefully consider the risks described in our filings with the Securities and Exchange Commission from time to time, including our most recent Annual Report and subsequent Flings, which are available on Otcmarkets.com. We expressly disclaim any obligation to update any forward-looking statement in the event it later turns out to be inaccurate, whether as a result of new information, future events or otherwise.

Source

UMAX Group Corp.
Las Vegas, NV 

View original content:http://www.prnewswire.com/news-releases/umax-group-corp–end-of-year-update-301196591.html

SOURCE UMAX Group Corp.

SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ — Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of SolarWinds Inc. (NYSE: SWI) against several of the members of its Board of Directors. 

The firm’s investigation concerns possible breaches of fiduciary duty by the members of SolarWinds’ Board of Directors by causing the sale of $286 million of SolarWinds stock while in possession of non-public information regarding the massive hacking of SolarWinds’ software.  It has been reported that on Friday, December 4, 2020, the cybersecurity firm FireEye discovered that it had been hacked via SolarWinds’ Orion software and that FireEye promptly informed SolarWinds. On the next trading day, Monday, December 7, 2020, SolarWinds’ major private equity investors, Silver Lake and Thoma Bravo, whose representatives are members of SolarWinds’ Board of Directors, sold $286 million shares of SolarWinds stock.  The next day, on December 8, it was publicly disclosed that SolarWinds’ software had been hacked.  Since that announcement SolarWinds’ stock price has declined approximately 39%. 

In an article published by The Washington Post on December 15, 2020, regarding those insider sales of SolarWinds’ stock, Jacob S. Frenkel, a former senior counsel in the SEC’s Division of Enforcement stated, “Of course the SEC is going to take a look at that” and “Large trades in advance of a major announcement, then an announcement: That is a formula for an insider trader investigation.” 

The Schubert Firm is investigating potential derivative claims based on harm the company has suffered as a result of possible breaches of fiduciary duty by the company’s directors and affiliated entities. For more information, please visit our website at https://www.classactionlawyers.com/solarwinds.  

If you own stock in SolarWinds and wish to obtain additional information about your legal rights, please contact us today.

About Schubert Jonckheer & Kolbe LLP

Schubert Jonckheer & Kolbe represents shareholders, employees, and consumers in class actions against corporate defendants, as well as shareholders in derivative actions against their officers and directors. The firm is based in San Francisco, and with the help of co-counsel, litigates cases nationwide.

Contact

Alexandra Green

Schubert Jonckheer & Kolbe LLP
[email protected]
Tel: 415-299-8207

View original content:http://www.prnewswire.com/news-releases/shareholder-alert-solarwinds-inc-nyse-swi-insiders-under-investigation-for-insider-trading-relating-to-cybersecurity-breach-301196615.html

SOURCE Schubert Jonckheer & Kolbe LLP

SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ — Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Amyris, Inc. (NASDAQ: AMRS) related to the company’s overstatements regarding future royalty payments on its financial statements and false or misleading statements concerning material weaknesses in the company’s internal controls.

In 2017, Amyris disclosed that it was addressing a material weakness in its internal controls over financial reporting with a remediation plan. Then, in December 2017, the company licensed its manufacturing plant, requiring the licensee to pay Amyris a $27.5 million use fee as well as royalty fees. However, on April 11, 2019, Amyris announced that material accounting errors were made related to the estimates for recognizing revenue for royalty payments and that it would have to restate several quarterly and annual financial reports. As a result, the price of Amyris’s stock fell nearly 24%.

This conduct has exposed the company to securities litigation in the U.S. District Court for the Northern District of California where it is alleged that Amyris misled investors about its efforts to improve internal controls over financial reporting and overstated its royalty revenues through improper revenue recognition. On October 5, 2020, U.S. District Judge Yvonne Gonzalez Rogers denied Amyris’s motion to dismiss the case, finding that the plaintiffs met the heightened pleading standards for alleged securities fraud, including alleging facts sufficient to create a “strong inference of scienter,” or intent to defraud investors, and that defendants’ statements did not qualify as forward-looking statements under the PSLRA’s safe harbor.

The Schubert Firm is investigating potential derivative claims based on harm the company has suffered as a result of potential breaches of fiduciary duty by Amyris’s officers and directors. For more information, please visit our website at http://www.classactionlawyers.com/Amyris.

If you own stock in Amyris and wish to obtain additional information about your legal rights, please contact us today.

About Schubert Jonckheer & Kolbe LLP

Schubert Jonckheer & Kolbe represents shareholders, employees, and consumers in class actions against corporate defendants, as well as shareholders in derivative actions against their officers and directors. The firm is based in San Francisco, and with the help of co-counsel, litigates cases nationwide.

Contact

Alexandra Green

Schubert Jonckheer & Kolbe LLP
[email protected] 
Tel: 415-299-8207

View original content:http://www.prnewswire.com/news-releases/shareholder-alert-amyris-inc-nasdaq-amrs-officers-and-directors-under-investigation-for-possible-breaches-of-fiduciary-duty-301196638.html

SOURCE Schubert Jonckheer & Kolbe LLP

SAN DIEGO, Dec. 21, 2020 /PRNewswire/ — (OTC Pink: TREP) Trucept Inc. has retained RBSM LLP to fully audit its financial records, with plans to uplist its publicly traded stock to the OTCQB. This move gives the company stock the advantage of being quoted by dealers.

Trucept CEO Norman Tipton said the audit should be completed within 90 days. “This is a very exciting time for Trucept and its investors,” he said.

RBSM LLP is a certified public accounting firm with operating offices in major cities in the United States, Europe and Asia. The firm provides professional accounting, auditing and tax services to a number of publicly held businesses as well as privately held companies. 

Safe Harbor:

Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management’s current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the U.S. Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K.

View original content to download multimedia:http://www.prnewswire.com/news-releases/trucept-launches-full-audit-aims-at-otcqb-uplist-301196471.html

SOURCE Trucept Inc.